Leila Taghiyar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Leila Taghiyar has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
Maryam Talebi Jouybari
Department of Stem Cell and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran
4 shared publications- Mohamadreza Baghaban Eslaminejad
Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran
4 shared publications Maryam Faeed
School of Biology, College of Science, University of Tehran, Tehran, Iran
3 shared publicationsFatemeh Mojtahedi
Department of Immunology, Shahid Sadoughi University of Medical Science, Yazd, Iran
2 shared publicationsMahnaz Babaahmadi
Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran
2 shared publicationsMahsa Ghiasvand
Department of Animal Sciences and Marine Biology, Faculty of Life Sciences and Biotechnology, Shahid Beheshti University, Tehran, Iran
2 shared publications
Latest Publications
- Open Access
- 23 April 2026
- Published by Springer Nature in BMC Molecular and Cell Biology
- Vol. 27 (1)
Immunomodulatory effects of TAK-242 on osteogenesis of mesenchymal stem cells in acute inflammatory conditions
Bone regeneration involves a complex series of stages that need proper regulation of the acute inflammatory response. Toll-like receptor 4 (TLR4) is expres
- 23 April 2026
- Published by Springer Nature in BMC Molecular and Cell Biology
- Vol. 27 (1)
Open AccessImmunomodulatory effects of TAK-242 on osteogenesis of mesenchymal stem cells in acute inflammatory conditions
Bone regeneration involves a complex series of stages that need proper regulation of the acute inflammatory response. Toll-like receptor 4 (TLR4) is expres
- 21 April 2026
- Vol. 28 (1) , 1-7
Converging Advances in Reproductive Biomedicine and Stem CellTechnology: Reflections from The 25th and 20thRoyan Congresses: A Commentary.
The 25th International Congress on Reproductive Biomedicine and the 20th International Congress on Stem Cell Biology and Technology, held in Iran, brought together leading global experts to discuss pioneering advances in stem cell research and reproductive medicine. Key topics included recent progress in somatic and pluripotent stem cells toward clinical applications, developments in regenerative medicine for diverse diseases, innovations in tissue engineering, the integration of artificial intelligence (AI) in biology research, and novel strategies for treating infertility. The congresses fostered collaboration and knowledge exchange across these rapidly evolving fields, highlighting the transformative potential of stem cells in regenerative medicine and their applications in reproductive health. Participation of 33 scientists from the United States, the United Kingdom, Germany, Austria, Italy, Belgium, Turkey, China, Russia, Japan, Sweden, Switzerland, Qatar, and India facilitated a rich exchange of ideas and broadened international perspectives. The insights and outcomes from these congresses are expected to shape ongoing research initiatives and clinical practices worldwide, emphasizing the importance of continued investment in these critical areas of medicine.
- 21 April 2026
- Vol. 28 (1) , 1-7
Converging Advances in Reproductive Biomedicine and Stem CellTechnology: Reflections from The 25th and 20thRoyan Congresses: A Commentary.
The 25th International Congress on Reproductive Biomedicine and the 20th International Congress on Stem Cell Biology and Technology, held in Iran, brought together leading global experts to discuss pioneering advances in stem cell research and reproductive medicine. Key topics included recent progress in somatic and pluripotent stem cells toward clinical applications, developments in regenerative medicine for diverse diseases, innovations in tissue engineering, the integration of artificial intelligence (AI) in biology research, and novel strategies for treating infertility. The congresses fostered collaboration and knowledge exchange across these rapidly evolving fields, highlighting the transformative potential of stem cells in regenerative medicine and their applications in reproductive health. Participation of 33 scientists from the United States, the United Kingdom, Germany, Austria, Italy, Belgium, Turkey, China, Russia, Japan, Sweden, Switzerland, Qatar, and India facilitated a rich exchange of ideas and broadened international perspectives. The insights and outcomes from these congresses are expected to shape ongoing research initiatives and clinical practices worldwide, emphasizing the importance of continued investment in these critical areas of medicine.
- Open Access
- 7 November 2024
- Published by Springer Nature in Stem Cell Research & Therapy
- Vol. 15 (1) , 1
Correction: Advancements in extracellular vesicle targeted therapies for rheumatoid arthritis: insights into cellular origins, current perspectives, and emerging challenges
- 7 November 2024
- Published by Springer Nature in Stem Cell Research & Therapy
- Vol. 15 (1) , 1
Open AccessCorrection: Advancements in extracellular vesicle targeted therapies for rheumatoid arthritis: insights into cellular origins, current perspectives, and emerging challenges
- Open Access
- 9 October 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-15
Extracellular vesicles derived from Msh homeobox 1 (Msx1)-overexpressing mesenchymal stem cells improve digit tip regeneration in an amputee mice model
In adult mammals, limb regeneration is limited by the absence of blastemal cells (BCs) and the lack of the regenerative signaling cascade. The utilization of transgenic cells circumvents the limitations associated with the absence of BCs. In a previous investigation, we successfully regenerated mouse phalanx amputations using blastema-like cells (BlCs) generated from bone marrow-derived mesenchymal stem cells (mBMSCs) overexpressing Msx1 and Msx2 genes. Recently, extracellular vesicles (EVs) have emerged as potent biological tools, offering a promising alternative to manipulated cells for clinical applications. This research focuses on utilizing BlCs-derived extracellular vesicles (BlCs-EVs) for regenerating mouse digit tips. The BlCs were cultured and expanded, and then EVs were isolated via ultracentrifugation. The size, morphology, and CD81 marker expression of the EVs were confirmed through Dynamic Light Scattering (DLS), Scanning Electron Microscope (SEM), and Western Blot (WB) analyses. Additionally, WB analysis demonstrated the presence of MSX1, MSX2, FGF8, and BMP4 proteins. The uptake of EVs by mBMSCs was shown through immunostaining. Effects on cell proliferation, migration, and osteogenic activity post-treatment with BlCs-EVs were assessed through MTT assay, scratch assay, and Real-time PCR. The regenerative potential of BlCs-EVs was evaluated in a mouse digit tip amputation model using histological assessments. Results indicated that BlCs-EVs enhanced several abilities of mBMSCs, such as migration, proliferation, and osteogenesis in vitro. Notably, BlCs-EVs significantly improved digit tip regeneration in mice, promoting the formation of new bone and nails, which was absent in control groups. In summary, BlCs-EVs are promising tools for digit tip regeneration, avoiding the ethical concerns associated with using genetically modified cells.
- 9 October 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-15
Open AccessExtracellular vesicles derived from Msh homeobox 1 (Msx1)-overexpressing mesenchymal stem cells improve digit tip regeneration in an amputee mice model
In adult mammals, limb regeneration is limited by the absence of blastemal cells (BCs) and the lack of the regenerative signaling cascade. The utilization of transgenic cells circumvents the limitations associated with the absence of BCs. In a previous investigation, we successfully regenerated mouse phalanx amputations using blastema-like cells (BlCs) generated from bone marrow-derived mesenchymal stem cells (mBMSCs) overexpressing Msx1 and Msx2 genes. Recently, extracellular vesicles (EVs) have emerged as potent biological tools, offering a promising alternative to manipulated cells for clinical applications. This research focuses on utilizing BlCs-derived extracellular vesicles (BlCs-EVs) for regenerating mouse digit tips. The BlCs were cultured and expanded, and then EVs were isolated via ultracentrifugation. The size, morphology, and CD81 marker expression of the EVs were confirmed through Dynamic Light Scattering (DLS), Scanning Electron Microscope (SEM), and Western Blot (WB) analyses. Additionally, WB analysis demonstrated the presence of MSX1, MSX2, FGF8, and BMP4 proteins. The uptake of EVs by mBMSCs was shown through immunostaining. Effects on cell proliferation, migration, and osteogenic activity post-treatment with BlCs-EVs were assessed through MTT assay, scratch assay, and Real-time PCR. The regenerative potential of BlCs-EVs was evaluated in a mouse digit tip amputation model using histological assessments. Results indicated that BlCs-EVs enhanced several abilities of mBMSCs, such as migration, proliferation, and osteogenesis in vitro. Notably, BlCs-EVs significantly improved digit tip regeneration in mice, promoting the formation of new bone and nails, which was absent in control groups. In summary, BlCs-EVs are promising tools for digit tip regeneration, avoiding the ethical concerns associated with using genetically modified cells.
- Open Access
- 4 September 2024
- Published by Springer Nature in Stem Cell Research & Therapy
- Vol. 15 (1) , 1-25
Advancements in extracellular vesicle targeted therapies for rheumatoid arthritis: insights into cellular origins, current perspectives, and emerging challenges
Rheumatoid arthritis (RA) remains a challenging chronic autoimmune disorder characterized by persistent joint inflammation and damage. While modern regenerative strategies, encompassing cell/stem cell-based therapies, gene therapy, and tissue engineering, have advanced tissue repair efforts, a definitive cure for RA remains elusive. Consequently, there is growing interest in developing targeted therapies that directly address the underlying mechanisms driving RA pathogenesis, such as extracellular vesicles (EVs). These small membrane-bound particles can modulate immune responses within the inflammatory microenvironment of damaged cartilage. To launch the clinical potential of EVs, they can be isolated from various cell types through several techniques. EVs can carry various bioactive molecules and anti-inflammatory or pro-regenerative drugs, deliver them directly to the affected joints, and affect the behavior of injured cells, making them a compelling choice for targeted therapy and drug delivery in RA patients. However, there are still several challenges and limitations associated with EV-based therapy, including the absence of standardized protocols for EV isolation, characterization, and delivery. This review provides a comprehensive overview of the cellular sources of EVs in RA and delves into their therapeutic potential and the hurdles they must overcome.
- 4 September 2024
- Published by Springer Nature in Stem Cell Research & Therapy
- Vol. 15 (1) , 1-25
Open AccessAdvancements in extracellular vesicle targeted therapies for rheumatoid arthritis: insights into cellular origins, current perspectives, and emerging challenges
Rheumatoid arthritis (RA) remains a challenging chronic autoimmune disorder characterized by persistent joint inflammation and damage. While modern regenerative strategies, encompassing cell/stem cell-based therapies, gene therapy, and tissue engineering, have advanced tissue repair efforts, a definitive cure for RA remains elusive. Consequently, there is growing interest in developing targeted therapies that directly address the underlying mechanisms driving RA pathogenesis, such as extracellular vesicles (EVs). These small membrane-bound particles can modulate immune responses within the inflammatory microenvironment of damaged cartilage. To launch the clinical potential of EVs, they can be isolated from various cell types through several techniques. EVs can carry various bioactive molecules and anti-inflammatory or pro-regenerative drugs, deliver them directly to the affected joints, and affect the behavior of injured cells, making them a compelling choice for targeted therapy and drug delivery in RA patients. However, there are still several challenges and limitations associated with EV-based therapy, including the absence of standardized protocols for EV isolation, characterization, and delivery. This review provides a comprehensive overview of the cellular sources of EVs in RA and delves into their therapeutic potential and the hurdles they must overcome.
- Open Access
- 21 June 2024
- Published by Springer Nature in Stem Cell Research & Therapy
- Vol. 15 (1) , 1-17
Osteochondral organoids: current advances, applications, and upcoming challenges
In the realm of studying joint-related diseases, there is a continuous quest for more accurate and representative models. Recently, regenerative medicine and tissue engineering have seen a growing interest in utilizing organoids as powerful tools for studying complex biological systems in vitro. Organoids, three-dimensional structures replicating the architecture and function of organs, provide a unique platform for investigating disease mechanisms, drug responses, and tissue regeneration. The surge in organoid research is fueled by the need for physiologically relevant models to bridge the gap between traditional cell cultures and in vivo studies. Osteochondral organoids have emerged as a promising avenue in this pursuit, offering a better platform to mimic the intricate biological interactions within bone and cartilage. This review explores the significance of osteochondral organoids and the need for their development in advancing our understanding and treatment of bone and cartilage-related diseases. It summarizes osteochondral organoids’ insights and research progress, focusing on their composition, materials, cell sources, and cultivation methods, as well as the concept of organoids on chips and application scenarios. Additionally, we address the limitations and challenges these organoids face, emphasizing the necessity for further research to overcome these obstacles and facilitate orthopedic regeneration.
- 21 June 2024
- Published by Springer Nature in Stem Cell Research & Therapy
- Vol. 15 (1) , 1-17
Open AccessOsteochondral organoids: current advances, applications, and upcoming challenges
In the realm of studying joint-related diseases, there is a continuous quest for more accurate and representative models. Recently, regenerative medicine and tissue engineering have seen a growing interest in utilizing organoids as powerful tools for studying complex biological systems in vitro. Organoids, three-dimensional structures replicating the architecture and function of organs, provide a unique platform for investigating disease mechanisms, drug responses, and tissue regeneration. The surge in organoid research is fueled by the need for physiologically relevant models to bridge the gap between traditional cell cultures and in vivo studies. Osteochondral organoids have emerged as a promising avenue in this pursuit, offering a better platform to mimic the intricate biological interactions within bone and cartilage. This review explores the significance of osteochondral organoids and the need for their development in advancing our understanding and treatment of bone and cartilage-related diseases. It summarizes osteochondral organoids’ insights and research progress, focusing on their composition, materials, cell sources, and cultivation methods, as well as the concept of organoids on chips and application scenarios. Additionally, we address the limitations and challenges these organoids face, emphasizing the necessity for further research to overcome these obstacles and facilitate orthopedic regeneration.
- Open Access
- 22 December 2023
- Published by Apex Publishing in Cell and Tissue Journal
- Vol. 14 (4) , 353-372
The Best Autologous Cell Sources for Articular Cartilage Regeneration with Critical Size Defects in an Ovine Knee Joints Model
هدف: استئوآرتریت (OA) یک بیماری ناتوان کننده با بار روانی و اقتصادی است. امروزه استفاده از سلولهای بنیادی مزانشیمی (MSCs) بسیار مورد توجه است. لذا انتخاب منبع سلولی مناسب یکی از چالشهای درمان OA است. هدف از این مطالعه بازسازی ضایعه غضروفی ( اندازه بحرانی) در زانوی گوسفند با استفاده از سلولهای اتولوگ کندروسیت، MSCs حاصل از بافت مغز استخوان (Bm-MSCs)و MSCs مشتق از بافت چربی (Ad-MSCs) که در شرایط کاملا یکسان جداسازی و کشت شده است. مواد و روشها: در مطالعه حاضر از گوسفند نژاد Najdi 12 ماهه استفاده شد. کندروسیتها از انتهای دنده، Bm-MSC از مغز استخوان و Ad-MSCs از بافت چربی گوسفند جدا شدند. سپس سلولهای جدا شده در محیطهای کشت و شرایط دمای 37 درجه سانتیگراد یکسان کشت شدند. پس از بررسی هوییت MSCs و کندروسیتها، مقدار ۱۰۶×۵ سلول در هر میلیلیتر ژل کلاژن نوع I کاشته شد. سپس به ضایعه غضروف در زانوی گوسفند پیوند شد. دو ماه پس از پیوند، میزان ترمیم با روش ماکروسکوپی و رنگآمیزی بافتشناسی H&E و Safranin fast green/O بررسی شد. نتایج: هوییت سلولهای MSCs کندروسیت تایید شد. بر اساس مشاهدات در گروههای درمانی، آسیب توسط بافت غضروف شبه هیالین در مقایسه با گروههای کنترل (untreated) و sham پر شده است. همچنین، سطح بافت تشکیل شده در Bm-MSCs و...
- 22 December 2023
- Published by Apex Publishing in Cell and Tissue Journal
- Vol. 14 (4) , 353-372
Open AccessThe Best Autologous Cell Sources for Articular Cartilage Regeneration with Critical Size Defects in an Ovine Knee Joints Model
هدف: استئوآرتریت (OA) یک بیماری ناتوان کننده با بار روانی و اقتصادی است. امروزه استفاده از سلولهای بنیادی مزانشیمی (MSCs) بسیار مورد توجه است. لذا انتخاب منبع سلولی مناسب یکی از چالشهای درمان OA است. هدف از این مطالعه بازسازی ضایعه غضروفی ( اندازه بحرانی) در زانوی گوسفند با استفاده از سلولهای اتولوگ کندروسیت، MSCs حاصل از بافت مغز استخوان (Bm-MSCs)و MSCs مشتق از بافت چربی (Ad-MSCs) که در شرایط کاملا یکسان جداسازی و کشت شده است. مواد و روشها: در مطالعه حاضر از گوسفند نژاد Najdi 12 ماهه استفاده شد. کندروسیتها از انتهای دنده، Bm-MSC از مغز استخوان و Ad-MSCs از بافت چربی گوسفند جدا شدند. سپس سلولهای جدا شده در محیطهای کشت و شرایط دمای 37 درجه سانتیگراد یکسان کشت شدند. پس از بررسی هوییت MSCs و کندروسیتها، مقدار ۱۰۶×۵ سلول در هر میلیلیتر ژل کلاژن نوع I کاشته شد. سپس به ضایعه غضروف در زانوی گوسفند پیوند شد. دو ماه پس از پیوند، میزان ترمیم با روش ماکروسکوپی و رنگآمیزی بافتشناسی H&E و Safranin fast green/O بررسی شد. نتایج: هوییت سلولهای MSCs کندروسیت تایید شد. بر اساس مشاهدات در گروههای درمانی، آسیب توسط بافت غضروف شبه هیالین در مقایسه با گروههای کنترل (untreated) و sham پر شده است. همچنین، سطح بافت تشکیل شده در Bm-MSCs و...
- 12 July 2023
- Published by Springer Nature
- p. 491-527
Validation of Tissue-Engineered Constructs: Preclinical and Clinical Studies
- 12 July 2023
- Published by Springer Nature
- p. 491-527
Validation of Tissue-Engineered Constructs: Preclinical and Clinical Studies
- 20 March 2023
- Published by Springer Nature in Cell and Tissue Banking
- Vol. 24 (4) , 711-724
A bioscaffold of decellularized whole osteochondral sheet improves proliferation and differentiation of loaded mesenchymal stem cells in a rabbit model
As a Natural decellularized extracellular matrix, osteochondral tissue is the best scaffold for the restoration of osteoarthritis defects. Bioscaffolds have the most similarly innate properties like biomechanical properties and the preserved connection of the bone-to-cartilage border. Although, their compacity and low porosity particularly, are proven to be difficulties of decellularization and cell penetration. This study aims to develop a new bioscaffold of decellularized osteochondral tissue (DOT) that is recellularized by bone marrow-derived mesenchymal stem cells (BM-MSCs), as a biphasic allograft, which preserved the interface between the cartilage section and subchondral bone of the joint. Whole osteochondral tissues of rabbit knee joints were sheeted in cartilaginous parts in 200–250 µm sections while connected to the subchondral bone and then fully decellularized. The BM-MSCs were seeded on the scaffolds in vitro; some constructs were subcutaneously implanted into the back of the rabbit. The cell penetration, differentiation to bone and cartilage, viability, and cell proliferation in vitro and in vivo were evaluated by qPCR, histological staining, MTT assay, and immunohistochemistry. DNA content analysis and SEM assessments confirmed the decellularization of the bioscaffold. Then, histological and SEM evaluations indicated that the cells could successfully penetrate the bone and cartilage lacunas in implanted grafts. MTT assay confirmed cell proliferation. Prominently, gene expression analysis showed that seeded cells differentiated into osteoblasts and chondrocytes in both bone and cartilage sections. More importantly, seeded cells on the bioscaffold started ECM secretion. Our results indicate that cartilage-to-bone border integrity was largely preserved. Additionally, ECM-sheeted DOT could be employed as a useful scaffold for promoting the regeneration of osteochondral defects.
- 20 March 2023
- Published by Springer Nature in Cell and Tissue Banking
- Vol. 24 (4) , 711-724
A bioscaffold of decellularized whole osteochondral sheet improves proliferation and differentiation of loaded mesenchymal stem cells in a rabbit model
As a Natural decellularized extracellular matrix, osteochondral tissue is the best scaffold for the restoration of osteoarthritis defects. Bioscaffolds have the most similarly innate properties like biomechanical properties and the preserved connection of the bone-to-cartilage border. Although, their compacity and low porosity particularly, are proven to be difficulties of decellularization and cell penetration. This study aims to develop a new bioscaffold of decellularized osteochondral tissue (DOT) that is recellularized by bone marrow-derived mesenchymal stem cells (BM-MSCs), as a biphasic allograft, which preserved the interface between the cartilage section and subchondral bone of the joint. Whole osteochondral tissues of rabbit knee joints were sheeted in cartilaginous parts in 200–250 µm sections while connected to the subchondral bone and then fully decellularized. The BM-MSCs were seeded on the scaffolds in vitro; some constructs were subcutaneously implanted into the back of the rabbit. The cell penetration, differentiation to bone and cartilage, viability, and cell proliferation in vitro and in vivo were evaluated by qPCR, histological staining, MTT assay, and immunohistochemistry. DNA content analysis and SEM assessments confirmed the decellularization of the bioscaffold. Then, histological and SEM evaluations indicated that the cells could successfully penetrate the bone and cartilage lacunas in implanted grafts. MTT assay confirmed cell proliferation. Prominently, gene expression analysis showed that seeded cells differentiated into osteoblasts and chondrocytes in both bone and cartilage sections. More importantly, seeded cells on the bioscaffold started ECM secretion. Our results indicate that cartilage-to-bone border integrity was largely preserved. Additionally, ECM-sheeted DOT could be employed as a useful scaffold for promoting the regeneration of osteochondral defects.